Arax Advisory Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.9K | Hold |
300
| – | – | ﹤0.01% | 1557 |
|
|
2025
Q1 | $24.3K | Hold |
300
| – | – | ﹤0.01% | 1217 |
|
|
2024
Q4 | $27K | Buy |
300
+75
| +33% | +$6.76K | ﹤0.01% | 1099 |
|
|
2024
Q3 | $22.2K | Hold |
225
| – | – | ﹤0.01% | 1041 |
|
|
2024
Q2 | $20.9K | Hold |
225
| – | – | ﹤0.01% | 947 |
|
|
2024
Q1 | $21.4K | Sell |
225
-100
| -31% | -$9.49K | ﹤0.01% | 658 |
|
|
2023
Q4 | $29K | Hold |
325
| – | – | ﹤0.01% | 590 |
|
|
2023
Q3 | $23.7K | Hold |
325
| – | – | ﹤0.01% | 556 |
|
|
2023
Q2 | $27K | Sell |
325
-190
| -37% | -$15.8K | ﹤0.01% | 541 |
|
|
2023
Q1 | $39.2K | Hold |
515
| – | – | 0.01% | 492 |
|
|
2022
Q4 | $42.7K | Hold |
515
| – | – | 0.01% | 469 |
|
|
2022
Q3 | $41K | Buy |
+515
| New | +$41K | 0.01% | 459 |
|
|
2020
Q4 | $54K | Buy |
387
+1
| +0.3% | +$140 | 0.01% | 400 |
|
|
2020
Q3 | $43K | Buy |
386
+193
| +100% | +$21.5K | 0.01% | 401 |
|
|
2020
Q2 | $22K | Buy |
+193
| New | +$22K | ﹤0.01% | 466 |
|
|
2019
Q3 | – | Sell |
-180
| Closed | -$16K | – | 614 |
|
|
2019
Q2 | $16K | Buy |
+180
| New | +$16K | 0.01% | 436 |
|
|
2018
Q4 | $18K | Hold |
251
| – | – | 0.01% | 386 |
|
|
2018
Q3 | $24K | Buy |
+251
| New | +$24K | 0.01% | 386 |
|